UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K/A

(Amendment No. 1)

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported) October 9, 2019 (October 2, 2019)

SUMMIT WIRELESS TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

(408) 627-4716

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company     x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

EXPLANATORY NOTE

On October 8, 2019, Summit Wireless Technologies, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Form 8-K”) with the U.S. Securities and Exchange Commission (the “SEC”), which disclosed that on October 2, 2019, pursuant to a Warrant Amendment and Exercise Agreement (the “Warrant Amendment Agreement”) entered into with certain holders (the “Holders”) of the Company’s common stock purchase warrants (the “Original Warrants”), the Company agreed to reduce the exercise price of the Original Warrants held by such Holders to $0.80 per share (the “Reduced Exercise Price”), and for each Original Warrant exercised by a Holder at the Reduced Exercise Price to purchase shares of common stock, par value $0.0001 per share, of the Company (the “Common Stock”), the Company agreed to reduce the exercise price of Original Warrants to purchase an equivalent number of shares of Common Stock to $0.79 (the “Amended Exercise Price”).

This Form 8-K/A is being filed to amend and restate the Original Form 8-K in its entirety in order to provide updated information about that closing and correct the number of Holders that entered into Warrant Amendment Agreements with the Company, as well as information regarding the number and type of Original Warrants that were exercised at the Reduced Exercise Price (such Original Warrants, as amended pursuant to the Warrant Amendment Agreement, the “Amended Warrants”), as the Original Form 8-K did not include disclosure regarding the receipt of exercises with respect to certain Amended Warrants that were received by the Company from Holders after market close on October 8, 2019. This Form 8-K/A is also being filed to refine the description of the Company’s obligation to register certain shares of Common Stock underlying the Company’s common stock purchase warrants pursuant to the Warrant Amendment Agreement.

Between October 2 and October 8, 2019, the Company and certain Holders of the Company’s common stock purchase warrants, including the Company’s Series D common stock purchase warrants (the “Series D Warrants”), Series F common stock purchase warrants (the “Series F Warrants”) and Series G common stock purchase warrants (the “Series G Warrants”), entered into the Warrant Amendment Agreement, pursuant to which the Company agreed to reduce the exercise price of (i) a subset of Original Warrants, including the Series D Warrants, held by certain of the Holders from $5.40 per share to the Reduced Exercise Price, (ii) the Series F Warrants held by certain of the Additional Holders from $3.60 per share to the Reduced Exercise Price and (ii) the Series G Warrants held by certain of the Additional Holders from $3.00 to the Reduced Exercise Price, in consideration for the exercise by such Holders of any of their Original Warrants at the Reduced Exercise Price. The Company entered into the Warrant Amendment Agreement with (i) twenty-six Holders of Series D Warrants, which Holders elected to exercise, in the aggregate, Series D Warrants for 589,772 shares of Common Stock at the Reduced Exercise Price and also had the exercise prices of their Series D Warrants reduced to the Amended Exercise Price with respect to an equal number of shares of Common Stock, (ii) five Holders of Series F Warrants, which Holders elected to exercise, in the aggregate, Series F Warrants for 430,866 shares of Common Stock at the Reduced Exercise Price and also had the exercise prices of their Series F Warrants reduced to the Amended Exercise Price with respect to an equal number of shares of Common Stock, (iii) three Holders of Series G Warrants, which Holders elected to exercise, in the aggregate, Series G Warrants for 104,165 shares of Common Stock at the Reduced Exercise Price and also had the exercise prices of their Series G Warrants reduced to the Amended Exercise Price with respect to an equal number of shares of Common Stock, and (iv) one Holder of an additional Original Warrant, which such Holder elected to exercise such other Original Warrant for 3,578 shares of Common Stock at the Reduced Exercise Price and also had the exercise price of Original Warrants reduced to the Amended Exercise Price with respect to an equal number of shares of Common Stock.

In connection with the Warrant Amendment Agreement entered into with the Holders of Series F Warrants, the Company also executed Amendment No. 1 to the Series F Warrants (the “Warrant Amendment”), pursuant to which each Series F Warrant was further amended to add, among other things, fundamental transaction and subsequent rights offerings provisions as well as a 9.99% beneficial ownership limitation (the “Beneficial Ownership Limitation”).

Pursuant to the Warrant Amendment Agreement entered into with the Holders of Series F Warrants and Series G Warrants, if the exercise of an Original Warrant at the Reduced Exercise Price would cause such a Holder to exceed the Beneficial Ownership Limitation, in lieu of receiving such number of shares of Common Stock in excess of the Beneficial Ownership Limitation, the Company will only issue such number of shares of Common Stock to such Holder as would not cause such Holder to exceed the maximum number of shares of Common Stock permitted under the Beneficial Ownership Limitation, and such Holder shall be issued, at an exercise price equal to the Reduced Exercise Price less $0.01 per share, pre-funded common stock purchase warrants covering such number of shares of Common Stock as would otherwise have been in excess of the Beneficial Ownership Limitation (the “Pre-Funded Warrants”, and collectively with the Original Warrants and the Amended Warrants, the “Warrants”). In connection with such exercises, two Holders were issued Pre-Funded Warrants to purchase an aggregate of 414,364 shares of Common Stock.

Additionally, pursuant to the Warrant Amendment Agreement, the Company agreed to prepare and file with the SEC, as soon as practicable, but in no event later than November 4, 2019, a registration statement on Form S-3 to register all shares of Common Stock underlying all of the Warrants.

The Company has received aggregate gross proceeds of approximately $1,200,000 from the transactions described herein from all of the Holders. The text of the press release regarding such exercises of the Original Warrants is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

The foregoing description of the Warrant Amendment Agreement, the Warrant Amendment and the Pre-Funded Warrants are qualified in their entirety by reference to the full text of the forms of the Warrant Amendment Agreement, the Warrant Amendment and the Pre-Funded Warrants, respectively, which will be filed as exhibits to the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2019.

The information contained above in Item 1.01 is hereby incorporated by reference into this Item 3.03.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.